StockData
Carlsmed, Inc. logo

Carlsmed, Inc. (CARL) stock

CARLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30120% above fair value
$17.22−0.15 (-0.86%)

Close on Nov 19, 2026Market cap $470.15MP/E –Yield –

Carlsmed net income

Net income is the profit left for shareholders after every expense, interest and tax.

Carlsmed's net income for the twelve months ending Jun 30, 2026 was -$36.35M. For fiscal 2025 it was -$29.63M.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$29.63M–
FY2024Dec 31, 2024-$24.26M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$10.51M–
Q1 FY2026Mar 31, 2026-$8.70M–
Q4 FY2025Dec 31, 2025-$8.61M–
Q3 FY2025Sep 30, 2025-$8.53M–
Q2 FY2025Jun 30, 2025-$6.77M–
Q1 FY2025Mar 31, 2025-$5.73M–
Q4 FY2024Dec 31, 2024-$4.72M–
Q3 FY2024Sep 30, 2024-$7.81M–
Q2 FY2024Jun 30, 2024-$6.28M–
Q1 FY2024Mar 31, 2024-$5.45M–

More Carlsmed figures

See a number that looks wrong?